CH
CKPT

CVI Holdings’s Checkpoint Therapeutics CKPT Stock Holding History

CVI Holdings’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-145,889
Closed -$328K – 286
2023
Q1 		$328K Buy
+145,889
New +$732K 0.12% 125
2021
Q1 		– Sell
-63,696
Closed -$1.69M – 615
2020
Q4 		$1.69M Sell
63,696
-198,559
-76% -$5.02M 0.32% 87
2020
Q3 		$7.03M Buy
+262,255
New +$6.3M 2.86% 8

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

CVI Holdings's CKPT Position: Q2 2023 in Review

CVI Holdings sold out of Checkpoint Therapeutics (CKPT) in Q2 2023, closing a stake of 145,889 shares — an estimated $328K sold.

CVI Holdings first reported a position in CKPT in Q3 2020 and held it in 3 quarters. The position peaked at $7.03M in Q3 2020. 34 funds tracked by Wall St. Rank hold CKPT as of Q2 2023.

  • CVI Holdings reported no remaining Checkpoint Therapeutics position as of Q2 2023 after selling out during the quarter.
  • CVI Holdings sold 145,889 Checkpoint Therapeutics shares in Q2 2023, an estimated $328K.
  • CVI Holdings first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 3 quarters.
  • CVI Holdings's Checkpoint Therapeutics position peaked at $7.03M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.